The record and distribution dates and the $ amount per share are announced on the fund company's website. Year-end distrtribution are even larger when capital gains, short- and long-term, are included. My fixed income funds have modest dividend distribution. Certainly nothing comparing to the past where 4 or 5% SEC yields were common in quality bond funds.

Thank you very much.
I have invested with Harbor funds for long time. I agree that the commentary from the subadvisor/manager is "light" even in annual reports. Andrew Foster of Seafarer funds and David Giroux of T. Rowe Price are exemplary on this aspect. Harbor hires managers with good track record and change them when their performance trail their benchmark for several years. Expense ratio of investor shares are reasonable and the lower fee institutional shares requires $50K.

One description: interest rates declined steadily for 150 years as the US economy matured and we weren't universally seen as an issuer of junk bonds, soared for 40 years during the "rise to global hegemony" phase and have now fallen for 40 years.
It's never safe to read too much into history, but an appreciation of how long "the long-term" can last might provide a useful frame for other discussions.
Just pondering, David

Casualties mounting.
https://www.usnews.com/news/politics/articles/2020-10-02/the-latest-wh-doctor-says-trump-will-continue-with-duties
https://thehill.com/homenews/campaign/519321-rnc-chair-tests-positive-for-coronavirus
https://thehill.com/homenews/news/519448-kellyanne-conway-tests-positive-for-covid-19

Yes, I was intrigued at the inception of MEGMX about Matthews’ chances with a diversified EM fund with new management. I decided to take a position in it and at the same time commit to ARTYX, in hopes that EMs would recover. Both positions made great moves up, with the Artisan fund doing better. The turmoil at Matthews and the apparent success of Artisan in attracting new talent led me to sell MEGMX but keep my EM allocation by increasing my position in ARTYX. I’m impressed that Artisan poached Lewis Kaufman (2015) and Reno Kanovich (2018) and got people from Matthews to come back. David Snowball’s commentary this month suggests that Artisan has concrete plans for future expansion.
Asset managers as businesses may face rocky roads ahead. In fact, from its IPO in 2013 until the present, Artisan Partners stock hasn’t seen any appreciation. While it’s hard to draw conclusions from the last 12 months or so, Schwab’s stock has disappointed at a time when the company has expanded its asset base. Personally, I am drawn to small MF firms for my actively managed holdings. Therefore, I own funds at Artisan, DF Dent, Brown Capital, Brown Advisory, and Grandeur Peak. With the exception of GP, I use Schwab for our Roths and taxable MF accounts. I just recently decided to part ways with the Bruce Fund, in part for the purpose of consolidating accounts. The redemption check arrived quickly enough via the USPS, but BOA has placed a 10-day hold on my deposit. Shades of “Hotel California.” Needless to say, investing in a boutique MF company that has no presence in the fund supermarkets has its drawbacks.

@Derf,
My initial (2020) purchase of PRLAX occurred on 2 successive days, April 2 and April 3. Was off close to 50% YTD at that time. Sold a couple small chunks (about 20%) late April / early June as it had risen quite a bit. As of yesterday, fund was still off 31% YTD. My 6-month gain’s probably going to be close to 15%. Beats 0.07% in a T-Bond money market fund. Been eying DODFX for a couple months. Should be a smoother ride. But doesn’t have the same upside potential.
Otherwise, you might be referring to roughly 4-5 years ago when I also played PRLAX for a quick gain. If that’s it, you have a damned good memory! They had an exit fee back than if the fund was held for fewer than 90 days. Actually sold it and paid the fee, since it had done so well.
“A bird in the hand is worth two in the bush.” - B/F

Today I received a note that Maryland's ORP (403b) program is changing some of its TIAA-CREF lineup. Of particular note is that although TIAA CREF is one of the 2 plan providers, they're dumping CREF Stock, Growth, and Global Equity VAs for actively managed funds. To my amazement, the 3 replacement funds all have noticeably higher ERs:
Old ...
CREF Stock Account Ticker Symbol: QCSTIX Net Expense Ratio: 0.30%
CREF Growth Account Ticker Symbol: QCGRIX Net Expense Ratio: 0.23%
CREF Global Equities Account Ticker Symbol: QCGRIX Net Expense Ratio: 0.27%
New ...
Hartford Core Equity Fund Ticker Symbol: HAITX Net Expense Ratio: 0.39%
T. Rowe Price Instl Large Cap Growth Fund Ticker Symbol: TRLGX Net Expense Ratio: 0.56%
Victory RS Global Fund Ticker Symbol: RGGRX Net Expense Ratio: 0.55%
They did swap VINIX (.04) with lower-priced VIIIX (.02) for a passive index, which was nice to see.
Granted, I am all-in with the LCV AF RWMGX (.29) in my 403B and would be glad to start regularly putting some money into TRLGX now that I have access to a solid TRP fund there. That said, while none of these fund fees are especially egregious in my view, I still find a retirement plans' move toward funds with *higher* ERs to be rather odd, especially in 2020 ... and articularly for a state university system that normally qualifies for the lowest-cost class in funds.
(Yes I'm making enquiries.)
.... which reminds me again why I don't like or trust state investment boards or advisors.

Dear friends,
We posted our early autumn issue of the MFO monthly this morning. I tried to focus a bit more on individual funds that might be worthy of attention.
Seven Canyons World Innovators (WAGTX) started life as Wasatch Global Tech, morphed into Wasatch World Innovators, and following founder Sam Stewart to his new firm and became Seven Canyons World Innovators. The manager commentaries are unusually lucid and thoughtful. I'm struck, in particular, by their discussion of whether the entire (developed) world has become Japan: slow growth, aging population, vast debt, no room for more monetary stimulus and at risk of stagnation. Their argument is "true enough, but some Japanese firms did fabulously well. Let's learn from them." Both raw and risk-adjusted performance is consistently top tier.
Harbor Global Leaders (HGGIX) sort of caught Ed's eye about a month ago, and I promised to write a bit about them. The short story is that this used to be a Marsico-led fund and, three years ago, became of somewhat different Sands-led one. The Sands team has had top tier returns but ... their Lipper peer group is a bit squishy since it's a "global" group that includes domestic funds and their shareholder communications are pretty bad. Like Fidelity, Harbor uses a template for their reports which limits the manager to about 100 words of useful content and they don't push any material that's not required. As a result, my read on them is a bit thin.
Evolutionary Tree Innovators just launched with the leadership of a guy who used to be a bigwig at Sands Capital. The strategy seems to be an ... uh, evolution of the domestic large-growth strategy he helped pursue at Sands. Two problems. (1) A near-institutional minimum and (2) limited access to role in the non-public version of the investment vehicles.
The Matthews folks have moved to Artisan, but it looks like they'll be working with private rather than public vehicles.
Lynn Bolin does another rich job of reasoning through his shopping list. Lynn is skeptical of the state of markets and the economy over the next five years and was looking for funds that (a) have flexibility in their mandate and (b) use it well. There's ground for lively discussion there.
Speaking of "lively discussion," the off-topic board is less closed than it was. With any luck at all, I've succeeded in modifying the settings so that folks can post there but O-T posts don't appear on the "recent discussions" view that is the default landing page for the discussion board. That way, if folks want to participate in off-topic discussions they can but the landing page highlights on-topic discussions instead. Thanks, especially, to O.J. for helping me think about this.
And thanks, especially, to The Shadow. Usually Briefly Noted is the product of parallel investigations: Shadow tracks filings and I track filings, with his work helping me be sure that I haven't screwed up and missed important stuff. This month was vaguely a disaster for me and I was about 95% dependent on his finds. Fortunately, Shadow does amazing work, which saved me. So, thanks!
David

@FD1k
>> 3) Healthcare got a lot more expensive since Obama care.
cites?
Here's one for ya:
https://www.statnews.com/2019/03/22/affordable-care-act-controls-costs/
@msf did a lot of substantiated posting in this area back when.

I'm not going to repost all that material, as people seem more interested in posturing with terse "narratives" and clickbait headlines than with numbers and objective analyses.
"Healthcare". What's that? National expenditures? National expenditures per capita? An analog of risk adjusted returns, e.g. improved health / change in cost?
"A lot more expensive". More expensive than what? Than it was in 2009? Certainly healthcare costs rise faster than inflation. That was true a decade ago, that's true now. So what? Not a single figure proffered, let alone two to show a comparison.
ACA "saved the U.S. $2.3 trillion"? Compared with what? "The bottom line: cumulatively from 2010 to 2017 the ACA reduced health care spending a total of $2.3 trillion."
National health expenditures in 2010 totaled $2.593T; by 2017 they totaled $3.487T. Each of the intervening years also experienced expenditures more than the 2010 baseline. Cumulatively, from 2010 to 2017 health expenditures increased by trillions of dollars.
https://www.cms.gov/files/zip/nhe-summary-including-share-gdp-cy-1960-2018.zip
"In 2017 alone, health expenditures were $650 billion lower than projected." So what's being compared are actual expenditures under the ACA with projected expenditures under the ACA. Actual expenditures being less that projected expenditures is evidence that projections didn't pan out, it's not evidence that the ACA had anything to do with it. Projected expenditures for 2017 may have been just as overstated under the old law as under the ACA.
As the column itself acknowledges, "Why have health care expenditures risen more slowly than projected? No one is entirely sure."
Here's a HealthAffairs piece on the subject:

Before the ACA, the uninsured rate hovered around 15 percent of the population. By 2018, that rate dropped to 8.5 percent, resulting in 18 million more people with coverage.
Efforts to achieve other policy goals were less successful. The ACA did not stem high and rapidly rising health care costs care for all Americans. Delivery system reforms advanced by the Centers for Medicare and Medicaid Services (CMS) Innovation Center have shown disappointing results, and mechanisms intended to rein in federal costs have been dropped.

https://www.healthaffairs.org/do/10.1377/hblog20200406.93812/full/
Regarding Obama's claim that family's premiums would be lowered by $2500, the opinion piece says that "the ACA has more than delivered on that promise, saving about $4,000 per family."
As I explained above, and the Health Affairs piece details, statnews' calculation of realized "savings" is flawed. Large savings have not been realized, nor, Obama's rosy projections aside, were they expected.
The 2009 CMS projections (pp. 16-18) cited by the statnews column, discusses the sources of savings. It characterizes the Act's expected impact as moderate: "overall moderate effects of the PPACA on NHE [National Health Expenditures]"
FactCheck (2008): Obama’s Inflated Health ‘Savings’, substantiates the CMS writing.
https://www.factcheck.org/2008/06/obamas-inflated-health-savings/

To ram through his 11th-hour Supreme Court nominee El Gran Jefe introduced Barrett to many senators who were maskless like him: https://politico.com/news/2020/10/02/trump-coronavirus-lawmakers-exposed-425026

Numbers as of 9/30/2020.

Observations for one month as of 9/30/2020:
Multi- Flat for the month but securitized shined with 1-2.9%/
HY Munis – Flat for the month but Nuveen (NHMAX,NVHAX) did better.
Inter term – (-0.1%) for the month. TGLMX (mostly securitized) did 0.4%.
Bank loans – up 0.3-4% for the month.
Uncontrain/Nontrad -0.2 for the month. Securitized(JASVX,DFLEX)
HY+EM – HY -0.9 and EM=-1.7% for the month with correlation to stocks.
Corp – down month. PIGIX -0.4%.
SP500(VFIAX)-Down monthth at -3.8, YTD=5.55%.
PCI-CEF huge upside at 7.1%. YTD still at -13.7%
My own portfolio
I started the month with IOFIX+DFLEX and replaced DFLEX with JASVX+NHMAX. It’s pretty obvious that funds loaded with securitized bonds are doing well. HY Munis don’t have a momentum yet but I bought NHMAX because it’s in my taxable and it showed a better momentum than others but the last 2 days are down, I was too early but now I’m watching closely. It was another good month for me.

FD, what is the source for the chart you posted? Many thanks.

Always masterful ...
https://am.jpmorgan.com/blob-gim/1383407651970/83456/MI-GTM-4Q20.pdf?segment=AMERICAS_US_ADV&locale=en_US

Sure, healthcare: https://thehill.com/policy/healthcare/517708-despair-at-cdc-after-trump-influence-i-have-never-seen-morale-this-low

gingrich the newt wrote that. makes perfect sense to him.

Numbers as of 9/30/2020.

Observations for one month as of 9/30/2020:
Multi- Flat for the month but securitized shined with 1-2.9%/
HY Munis – Flat for the month but Nuveen (NHMAX,NVHAX) did better.
Inter term – (-0.1%) for the month. TGLMX (mostly securitized) did 0.4%.
Bank loans – up 0.3-4% for the month.
Uncontrain/Nontrad -0.2 for the month. Securitized(JASVX,DFLEX)
HY+EM – HY -0.9 and EM=-1.7% for the month with correlation to stocks.
Corp – down month. PIGIX -0.4%.
SP500(VFIAX)-Down monthth at -3.8, YTD=5.55%.
PCI-CEF huge upside at 7.1%. YTD still at -13.7%
My own portfolio
I started the month with IOFIX+DFLEX and replaced DFLEX with JASVX+NHMAX. It’s pretty obvious that funds loaded with securitized bonds are doing well. HY Munis don’t have a momentum yet but I bought NHMAX because it’s in my taxable and it showed a better momentum than others but the last 2 days are down, I was too early but now I’m watching closely. It was another good month for me.

An example of how Covid-19 effects continue to ripple through the economy. Forbes
“ In March ... American Airlines, without notice, cancelled its order for 1.35 million bags – or 1.7 million pounds – of mixed almonds, cashews, pecans and pistachios, the much-loved mix that it had been serving warm to its premium-class passengers for more than 30 years.“
-
Related : After posting the above, this more sobering story broke:
Fort Worth-Based American Airlines to Cut 19,000 Jobs CNBC
The flowers died on fields of hope
All the way from east to west
Where the mighty winds will blow
I'll put my dreams to rest
This scary monster is very much alive
Like a hundred years ago
From: The World We Used to Know

he got healthcare done, bwahaha

wait, maybe he did, and is !
https://thehill.com/opinion/healthcare/518584-yes-trump-has-a-health-care-plan-he-has-been-implementing-it

The above report is from 2015. What happened to Median household income in the United States from 1990 to 2019? It went up very nicely from 2015 to 2019 under you know what president

Correlation is not causation.

VLAAX has good recent performance and is catching the attention of many. I want to point out this fund holds a weight of 47 in the growth arena per M* which is much higher than an avg 50/70 fund with a yield much lower 0.38% than an average balanced fund. The P/B is also indicating higher than avg at 4.09. Not saying you should buy it and not saying you should not buy it. I am suggesting you understand what you own.

Take a look at Fidelity Emerging asia. Provides exposure to China and other key Asian emerging markets like India but that is balanced out by holdings in Japan. The portfolio manager has a stong background as a technology analyst and thus both tech and communication services are well represented. What I really like is the consistency of the fund. It rates in the top 10% of its category for the past 1, 3 , 5 and 10 year periods. I plan to add it right after the election. Here is the report from morningstar..
Fidelity® Emerging Asia (FSEAX) Performance | Morningstar
https://www.morningstar.com/funds/xnas/fseax/performance